• Most nmCRPC Patients Can Safely Take Full Dose of Nubeqa, Trial Analysis Shows
  • Phase 1 Trial of Oral Treatment for Metastatic CRPC Doses First Patient
  • Lynparza’s Approval Favored in EU for mCRPC Patients with BRCA Mutations
  • NCI Grant to Probe Link Between Prostate Cancer and Fatty Cells in Bone Marrow
  • NIH Grants Dartmouth Team $2.5M to Develop Device for Detecting Cancer Cells
  • IPCR Launches Exercise Video Series for Prostate Cancer Patients
  • ‘Eat It to Beat It’ Challenge to Honor Prostate Cancer Awareness Month
  • FDA Approves Blood Test That Can Identify Cancers Eligible for Targeted Therapies
  • Tolmar Affirms Full Supply of Eligard for Palliative Treatment of Prostate Cancer
  • Google AI System Outperforms General Pathologists in Grading Prostate Cancers, Study Finds
  • Dosing Begins in Trial of PET Imaging Agent to Detect Prostate Cancer’s Return
  • Cryotherapy May Ably Treat Intermediate-risk Prostate Cancer